Stay updated on Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial
Sign up to get notified when there's something new on the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page.

Latest updates to the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe study status was updated from enrollment by invitation to Completed, with the completion date recorded as 2026-03-24 and the update posted 2026-03-27. The enrollment-by-invitation note and related estimated dates were removed.SummaryDifference0.5%

- Check33 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page. This indicates a newer version of the study details page.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page now shows a new site revision label (v3.4.2). An older government funding maintenance notice has been removed; no study content or data is changed.SummaryDifference0.4%

- Check83 days agoChange DetectedThe page now shows a site-wide funding-status notice and updates the version to v3.4.1 (replacing v3.4.0), with no changes to study-specific content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page.